Cargando…
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common liver malignancy associated with poor prognosis. Treatment options are limited partially due to resistance to traditional chemotherapeutic agents. Immunotherapy has changed the treatment landscape in metastatic and recurrent solid tum...
Autores principales: | Kole, Christo, Charalampakis, Nikolaos, Tsakatikas, Sergios, Vailas, Michail, Moris, Dimitrios, Gkotsis, Efthymios, Kykalos, Stylianos, Karamouzis, Michalis V., Schizas, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600093/ https://www.ncbi.nlm.nih.gov/pubmed/33020428 http://dx.doi.org/10.3390/cancers12102859 |
Ejemplares similares
-
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
por: Kole, Christo, et al.
Publicado: (2022) -
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
por: Charalampakis, Nikolaos, et al.
Publicado: (2022) -
Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?
por: Kotsifa, Evgenia, et al.
Publicado: (2022) -
Hereditary Diffuse Gastric Cancer: A 2022 Update
por: Kole, Christo, et al.
Publicado: (2022) -
Laparoscopic parastomal hernia repair: keyhole, Sugarbaker, sandwich, or hybrid technique with 3D mesh? An updated systematic review and meta-analysis
por: Kritharides, Nicos, et al.
Publicado: (2023)